Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 19/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.41 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8540934 | 1.00 | DPP4 (0.41) | DPP4DPP8DPP9RIPK1 | |
| SCHEMBL8300456 | 0.81 | DPP4 (0.41) | DPP4DPP8DPP9 | |
| SCHEMBL8300453 | 0.81 | DPP4 (0.41) | DPP4DPP8DPP9 | |
| SCHEMBL18701586 | 0.78 | RIPK1 (0.44) | DPP4RIPK1 | |
| SCHEMBL14899497 | 0.74 | DPP7 (0.53) | DPP4DPP8DPP9 | |
| SCHEMBL9258699 | 0.73 | RIPK1 (0.44) | RIPK1 | |
| SCHEMBL9258703 | 0.73 | RIPK1 (0.44) | RIPK1 | |
| SCHEMBL8544519 | 0.72 | RIPK1 (0.40) | DPP4RIPK1 | |
| SCHEMBL8544522 | 0.72 | RIPK1 (0.40) | DPP4RIPK1 | |
| SCHEMBL18701935 | 0.72 | RIPK1 (0.40) | DPP4RIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0565396-B1 | 1-[2-(arylsulfonylamino)-1-oxoethyl]piperidine derivatives, their preparation and use in therapy | SYNTHELABO (FR) | 1998-01-07 | — | — | EP | disclosed |
| US-5453430-A | Anticoagulants | SYNTHELABO (FR) | 1995-09-26 | — | — | US | disclosed |
| EP-0565396-A1 | 1-(2-arylsulfonylamino)-1-oxoethyl)-piperidine derivatives, their preparation and use in therapy | SYNTHELABO (FR) | 1993-10-13 | — | — | EP | disclosed |